


|
|
|
|
Search
05/06/2019 Jeff Bean, DPM
Laser Treatment Reported Ineffective for Onychomycosis Related to Diabetes (Adam Landsman, DPM, PhD)
I have seen successful clearing of mycotic toenails with laser treatment most of the time. However, it almost never works as mono-therapy. It must be combined with consistent use of effective topical medications, frequent thorough debridement, consistent shoe disinfection, and treatment of the skin with a topical antifungal cream. If you are missing any of these components, you are simply “shoveling in a fungal snowstorm.” It’s like giving antibiotics but not climbing out of the septic tank with your open wound.
But wait, there’s more. The condition will almost always recur without long term prevention, including shoe disinfection, topical medication a few times a week, treating any tinea pedis as soon as it appears, treating any underlying conditions (ie., hyperhidrosis), and returning to twice daily treatment (and perhaps another laser treatment) whenever an area of onychomycosis first re-appears. I tell each patient that treatment WILL NOT WORK if they do not do ALL of these things. I have been doing this for 7 or 8 years with a very high success rate. We track those patients we can still find, and have had 85% or higher success rate among the compliant and committed patients each year.
Does the right wavelength of laser kill dermatophytes? Yes it does. Does it kill them all (and their spores)? Get real, no way. Can it cure or even cosmetically clear moderate onychomycosis by itself? Almost never. Will it work on extreme toenails? No, there is too much nail unit and matrix deformity to expect a crazy nail to normalize even if every organism were eliminated. Can it be the foundation of a very effective multi-faceted treatment program that will clear the toenails most of the time? Absolutely, but only for the motivated patients. Is the clearing permanent? ONLY if your patient sticks with the preventative maintenance program.
I think oral terbinafine would also have a >85% success rate if all the other pieces were in place. Fungus is everywhere. Those who are susceptible to it WILL be infected eventually. Those who cure it WILL be re-infected without prophylaxis. There is NO single therapy that is a lasting cure. However, there are protocols that work VERY well if the you cover all the bases and the patient is motivated to stick with it. It’s not even time-consuming or expensive for them (as long as you are not greedy with your pricing). They just have to remember to stick with it. Many women and a few men really will do this successfully if you teach it comprehensively. The argument that any single treatment does not reliably cure onychomycosis is undeniably true. These studies are asking an important question, but not the entire question. Does any single treatment cure all plantar fasciitis or rheumatoid arthritis, or most other chronic conditions? No way! I urge everyone who treats this stubborn problem to look at the bigger picture, develop a protocol, treat it thoroughly from every necessary angle, and you (and the motivated patient) will usually achieve a lasting difference.
Jeff Bean, DPM, Carson City, NV
Other messages in this thread:
05/10/2019 Bryan C. Markinson, DPM
Laser Treatment Reported Ineffective for Onychomycosis Related to Diabetes (Adam Landsman, DPM, PhD)
When the laser technology achieved very anemic approval for "temporary clearing of nails," as did all lasers marketed for onychomycosis, it seemed as if every five minutes in NYC a DPM was advertising on the radio about it. Unfortunately, the overwhelming majority of the ads gave the listener the impression that laser was a quick "zap" cure that was permanent, without actually saying so. Most ads pushed the limit excessively and unethically to give that impression without running afoul of the law. Some state boards actually took action against this advertising.
Soon enough, the Internet was full of patient postings that laser treatment for onychomycosis was a sham. How unfortunate to ruin a potentially efficacious adjunctive treatment based on overzealous marketing and no science whatsoever accept a declaration of FDA approval or clearance. Patients showed up regularly in my office with histories of the lasers being applied to nails that were never properly worked up or laboratory confirmed, further creating undeserved impressions that the lasers in use were not efficacious.
Around that time, the principals of two laser companies met with me to discuss opportunities to be a key opinion leader in behalf of the companies. I was certainly interested in working with one of them (the other had delays in getting FDA clearance) with one significant condition, and that was that they reign in their users of the laser from their marketing tactics that were successful, but clearly unethical and potentially damaging to the technology, and the podiatry profession. I had similar discussions with several of the laser companies getting into the market.
Universally, the principals of the companies rejected my concerns and stated that they have no control over what the doctors do once they buy the machine, and made no attempt to even consider my points for obvious reasons. Several sales representatives for the various companies addressed my concerns of lack of laboratory confirmation before use of the laser as not "major" because the procedure was largely cosmetic.
Still to this day, the true potential for these technologies go unknown due to lack of good studies in peer reviewed literature, though podiatrists all over the country have their "protocols" which they tout as very successful but refuse to publish. Interestingly, and expectedly, the dermatology profession has never been impressed and has not at all embraced it for treatment of onychomycosis. So although Dr. Landsman's protestations that laser technology has gotten a bad rap is a position I agree with, he and others may have done more to reduce the root causes of this, which largely can be laid at the feet (no pun intended) to no one else but ourselves.
Bryan C. Markinson, DPM, NY, NY
05/09/2019 Allen Jacobs, DPM
Laser Treatment Reported Ineffective for Onychomycosis Related to Diabetes (Adam Landsman, DPM, PhD)
Mark Twain stares that “facts are stubborn things. But statistics are pliable”. Let us look at facts.
Fact: Current “ approved lasers for onychonycosis “ have been cleared through the 510k process, not by virtue of prof of efficacy.
Fact: Treatments which affect the appearance of a nail do not imply resolution of fungal infection; Fact: We do not know if special populations (eg: diabetics, immunocompromised, chemotherapy) respond differently;
Fact: The FDA recommended labeling states the following; “ indicated for adjunctive use in the temporary increase in clear nail in patients with onychomycosis. This device should be used with manual debridement and/or topical antifungal products.”
Fact: The FDA further notes; “WARNING: these devices should be used with caution in patients with diabetes, peripheral vascular disease, or immune-suppression, or any other medical state which warrants definitive antifungal therapy“ (note: it is not potential physical harm from the laser, it is the denial of needed treatment which is the issue );
Fact: The FDA is clear that “this device has not demonstrated effectiveness in the treatment of onychomycosis. It is cleared only for improvement in nail appearance “
Fact: Published studies are frequently of small sample size, often lack a control group, demonstrate limited efficacy, and often do not require either clinical or mycological cure as end points
Fact: Of those studies published, the average mycological cure rate is 11%, clinical cure rate 13%, and “ clinical improvement ranging from 36% to 67%; these do not meet criteria for medical improvement
As Mark Twain so aptly stated; “statistics are like garbage. You better know what you’re going to do with it before you collect it.”
Allen Jacobs, DPM, St. Louis, MO
05/06/2019 Allen Jacobs, DPM
Laser Treatment Reported Ineffective for Onychomycosis Related to Diabetes (Adam Landsman, DPM, PhD)
As do many in our profession, I hold Dr. Adam Landsman with the highest regard. His commentary is well taken and deserves consideration. Dr. Landsman, however, fails to inform the readers of his research and consulting relationship with laser manufacturers from which relations he was rightfully paid. This is the very type of potential bias and conflict of interest which concerns me. Dr. Landsman’s published works on the subject of laser management of onychomycosis are worthy of review and consideration. His insight and conclusions are always of import to our profession.
Dr. Landsman dutifully notes that lasers are cited as ineffective for the treatment of onychomycosis because the condition is “incurable“. Why then suggest that lasers effect a cure? In point of fact, FDA published guidelines call for interdiction of advertising which suggests that lasers are effective for treating onychomycosis. That is exactly by point. Switch and bait advertising such as “FDA approved“ refer to safety, not efficacy.
For as many years as I can recall (and those years are increasingly difficult to recall), Warren Joseph has called for active treatment of this disorder, not just palliation. I should like to modify his call in the following manner; EFFECTIVE active management and control.
It is my firm belief that our profession, as American and British dermatology associations, should establish recommended protocols for the EVALUATION and TREATMENT of onychomycosis. Establishment of standards of care, absent corporate bias and absent conflict of interest, provides preferred clinical guidelines which both benefits patients and Podiatric physicians. The relative free for all “anybody with a checkbook can purchase lecture time “at a CME meeting must be discontinued.
I can guarantee that if I were to give an “unrestricted educational grant “of $30,000 to a meeting, you’d hear me lecturing on moonlight curing onychomycosis. And I can equally guarantee you that if I pay speakers $2,000, I’d have no shortage of thought leaders climbing over each other to give those lectures with corporate approved slides. And finally, if I offer free steak dinner and drinks, I’d fill the room for those speakers.
Never forget: it is the first mission of corporations to sell product and make money. It is your first mission and ONLY mission (legally a duty) to provide appropriate medical to those seeking your guidance. Those receiving corporate money for CME activities are serving two masters, one of which may not be that of patient best interest.
Allen Jacobs, DPM, St. Louis, MO
05/06/2019 Jeff Bean, DPM
Laser Treatment Reported Ineffective for Onychomycosis Related to Diabetes (Adam Landsman, DPM, PhD)
I have seen successful clearing of mycotic toenails with laser treatment most of the time. However, it almost never works as mono-therapy. It must be combined with consistent use of effective topical medications, frequent thorough debridement, consistent shoe disinfection, and treatment of the skin with a topical antifungal cream. If you are missing any of these components, you are simply “shoveling in a fungal snowstorm.” It’s like giving antibiotics but not climbing out of the septic tank with your open wound.
But wait, there’s more. The condition will almost always recur without long term prevention, including shoe disinfection, topical medication a few times a week, treating any tinea pedis as soon as it appears, treating any underlying conditions (ie., hyperhidrosis), and returning to twice daily treatment (and perhaps another laser treatment) whenever an area of onychomycosis first re-appears. I tell each patient that treatment WILL NOT WORK if they do not do ALL of these things. I have been doing this for 7 or 8 years with a very high success rate. We track those patients we can still find, and have had 85% or higher success rate among the compliant and committed patients each year.
Does the right wavelength of laser kill dermatophytes? Yes it does. Does it kill them all (and their spores)? Get real, no way. Can it cure or even cosmetically clear moderate onychomycosis by itself? Almost never. Will it work on extreme toenails? No, there is too much nail unit and matrix deformity to expect a crazy nail to normalize even if every organism were eliminated. Can it be the foundation of a very effective multi-faceted treatment program that will clear the toenails most of the time? Absolutely, but only for the motivated patients. Is the clearing permanent? ONLY if your patient sticks with the preventative maintenance program.
I think oral terbinafine would also have a >85% success rate if all the other pieces were in place. Fungus is everywhere. Those who are susceptible to it WILL be infected eventually. Those who cure it WILL be re-infected without prophylaxis. There is NO single therapy that is a lasting cure. However, there are protocols that work VERY well if the you cover all the bases and the patient is motivated to stick with it. It’s not even time-consuming or expensive for them (as long as you are not greedy with your pricing). They just have to remember to stick with it. Many women and a few men really will do this successfully if you teach it comprehensively. The argument that any single treatment does not reliably cure onychomycosis is undeniably true. These studies are asking an important question, but not the entire question. Does any single treatment cure all plantar fasciitis or rheumatoid arthritis, or most other chronic conditions? No way! I urge everyone who treats this stubborn problem to look at the bigger picture, develop a protocol, treat it thoroughly from every necessary angle, and you (and the motivated patient) will usually achieve a lasting difference.
Jeff Bean, DPM, Carson City, NV
05/05/2019 Richard Silverstein, DPM
RE: Laser Treatment Reported Ineffective for Onychomycosis Related to Diabetes (Adam Landsman, DPM, PhD)
I whole heartedly agree that we must be very careful when treating onychomycosis with lasers. If there is an active tinea infection it must be treated along with the onychomycosis, if optimal results are desired. Culture results demonstrating the presence of a fungal infection is always an appropriate step prior to initiating therapy.
Why is it we must be on guard especially in our diabetic and vascularly compromised patients? I presume it is to prevent a burn from the heat build-up of a thermal laser. Our diabetics who may have neuropathy may not be able to tell us that something hurts when heat is generated within the nail plate or nail bed. We also don’t want to cause a burn in patients whose circulation is less than adequate to heal a thermal injury.
This is the crux of my issue when the term “laser” is tossed about. Not all lasers produce heat. If the FDA is using this term, it should responsibly be preceded by “thermal" or "non- thermal". There is absolutely no contraindication in diabetics or PAD patients to use an automated, non-thermal, FDA cleared laser for onychomycosis (The Lunula Laser).
In the thousands of patients that have been treated with the only low level, non-thermal laser (510 K cleared by the FDA) with a wavelength of 405 nm and 635 nm there has never been any adverse event reported.
In fact, due to the nature of the mechanism of action of low level lasers, photobiomodulation, there is a sustained hyperemic effect which stimulates the bodies immune system to help fight the fungal infection. This has been confirmed with ultrasound.
One size never fits all when tailoring a treatment protocol for a patient. Some do not want to be placed on medication no matter how safe it is. Others want to try everything at once: creams, pills and non-thermal laser included. And yet others come in asking for non- thermal laser therapy, specifically. Our job is to provide the relevant information so an educated decision can be made by the patient.
Disclosure: I am a consultant for the Erchonia Laser Corporation
Richard Silverstein, DPM, Havre de Grace, MD
|
|
|
|
|